Article Details

Neoadjuvant IO Response Suggestive of Long-Term Benefit in HPV– HNSCC - Targeted Oncology

Retrieved on: 2021-09-25 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Neoadjuvant IO Response Suggestive of Long-Term Benefit in HPV– HNSCC - Targeted Oncology. View article details on hiswai:

Excerpt

This can best be seen, Uppaluri said, in terms of pathologic tumor response after neoadjuvant therapy, which is an indication of activated immune response.

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up